BioCentury
ARTICLE | Editor's Commentary

Pharma CEOs should demand Prasad’s departure

FDA’s CBER director is endangering patients, damaging FDA, and destabilizing drug companies — and Moderna’s flu vaccine won’t be his last target

By Steve Usdin, Washington Editor 
February 12, 2026 6:50 PM UTC

It is past time for life sciences industry leaders to publicly demand Vinay Prasad’s firing.

If FDA Commissioner Marty Makary is unwilling to part with Prasad, he must go as well...

BCIQ Company Profiles

U.S. Food and Drug Administration (FDA)